Starting Strong: Initial Evaluation of the Patient With HCV

Slides:

Advertisements

Similar presentations

Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.

Advertisements

V.E.I.L. Liver Cancer Prevention. 1. Vaccination Birth dose + 2 Universal for those not already chronics Screening pregnant women Catch up vaccination.

Hepatitis C for the General Practitioner Morris Sherman MB BCh PhD FRCP(C) University of Toronto January 2013.

Modelled impact of antiviral therapy on the future burden of HCV disease in Scotland Testing/Treatment/Care Working Group, 11 th Sept 2007.

Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.

What is the contribution of alcohol to liver disease in the hepatitis C infected population. The epidemiological evidence Hamish Innes Research Fellow.

Hepatitis B virus infection in renal transplant recipients

Where Are We on the Path to Elimination of Chronic Hepatitis C?

Addressing Viral Hepatitis

Multimodal Management of Opioid-Induced Constipation

Interactive Workshop.

Hepatitis B and C management pathways in prison:

Chronic HCV Infection and CKD

Core Competency 4: HCV Treatment

Talking to Patients About HCV Treatment

A Review of the Critical Role of Imaging in Primary Liver Malignancy

HCV. The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease.

Chronic Hepatitis C Virus Infection

The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting Adnan Said, John Williams, Jeremy Holden,

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

HCV: Who Should We Screen and Why?

More Than Meets the Eye: Identifying Who Is at Risk for NASH

Introduction. Looking Beyond HIV Infection: CCR5 Blockade as an Immunomodulatory Concept

Expanding the Universe of Viral Hepatitis Treaters

HCV Care in Unique Patient Populations

The HCV Revolution: Are You and Your Practice Ready?

Best Practices in Screening and Linkage to Care in Hepatitis C Virus

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Complicated Cases in Ulcerative Colitis

Transition of Care in Epilepsy Among Patients Entering Long-Term Care

More Than Treatment.

Chronic Idiopathic Urticaria

Screening and Diagnosing Postpartum Depression

HBV Infection: Some Sobering Facts

HBV Care Models: Community Collaborations for Best Practices

Decision-making in the eRA of Treating to Target

Evaluation of the Patient With HCV Infection

What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?

Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.

Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent.

Hepatitis C in the HIV-infected patient

HCV Protease Inhibitors in Clinical Practice

The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting Adnan Said, John Williams, Jeremy Holden,

Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?

Care of the Treatment-naive Patient With HCV/HIV Coinfection

From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP

Pseudobulbar Affect or Psychiatric Condition?

Primary Biliary Cholangitis

When Is Intrathecal Drug Delivery Appropriate?

Advances in the Treatment of HCV Genotype 3 and HIV/HCV Coinfection

Hepatitis C: After the Diagnosis

Managing Age-Related Clinical Issues in Hemophilia

A Guideline-Based Approach to HCV Care

HCV Protease Inhibitors in Clinical Practice

Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.

Current Controversies and Advances in Hepatorenal Syndrome

What Does the Future Hold and What Will It Mean for Patients?

Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators

Improving Outcomes in Patients With SSc-ILD

Assessing the Burden of Hyperkalemia

Disease Burden of VTE Phases of VTE Treatment.

What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.

Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg

When Is Intrathecal Drug Delivery Appropriate?

Assessing the Burden of Hyperkalemia

Removing Barriers in the HCV Cascade of Care

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Using Biomarkers in MS: Initiating With the Right Therapy in Clinical Practice.

NAFLD and NASH in Europe and Canada

Presentation transcript:

Starting Strong: Initial Evaluation of the Patient With HCV

Prevalence of HCV Infection in the United States

Chronic HCV Infection Burden of Disease

More Patients Are Being Linked to Care and Treatment More Providers Needed to Treat HCV Infection

Treatment of HCV Infection What's Changed?

Recommendations for the Identification of Chronic HCV Infection Among Persons Born 1945-1965

HCV Screening in High-Risk Groups

Next Steps After a Positive HCV Screening Test

What Else Should You Assess For?

Don’t Let the Clinical Exam Fool You

Cirrhosis vs No Cirrhosis

How Do You Determine Whether a Patient Has Cirrhosis?

Serum Markers: What They Tell You Cirrhosis or No Cirrhosis?

Liver Ultrasound When Should You Use It? What Does It Tell You?

Liver Wellness Starts With Abstinence From Alcohol

Summary

Abbreviations

Abbreviations (cont)